T1	Pharmacological_substance 29 40	tolterodine
N1000 	Reference T1 MeSH:D000068737	tolterodine
T2	Pharmacological_substance 45 53	warfarin
N1001 	Reference T2 MeSH:D014859	warfarin
T3	Disorder 91 111	deep vein thrombosis
N1 	Reference T3 UMLS:C0149871	deep vein thrombosis
T4	Disorder 116 134	pulmonary embolism
N2 	Reference T4 UMLS:C0034065	pulmonary embolism
T5	Pharmacological_substance 149 157	warfarin
N1002 	Reference T5 MeSH:D014859	warfarin
T6	Disorder 169 197	thromboembolic complications
T7	Pharmacological_substance 269 297	Extended-release tolterodine
T9	Disorder 337 355	overactive bladder
N3 	Reference T9 UMLS:C0878773	overactive bladder
T10	Pharmacological_substance 455 463	warfarin
N1003 	Reference T10 MeSH:D014859	warfarin
T11	Pharmacological_substance 490 501	tolterodine
N1004 	Reference T11 MeSH:D000068737	tolterodine
T12	Pharmacological_substance 610 621	tolterodine
N1005 	Reference T12 MeSH:D000068737	tolterodine
T13	Pharmacological_substance 730 741	tolterodine
N1006 	Reference T13 MeSH:D000068737	tolterodine
T14	Pharmacological_substance 746 754	warfarin
N1007 	Reference T14 MeSH:D014859	warfarin
T15	Pharmacological_substance 829 837	warfarin
N1008 	Reference T15 MeSH:D014859	warfarin
T22	Speculation_cue 0 8	Probable
T23	Subject 55 72	53-year-old woman
T19	Combination 742 745	and
T17	Speculation_cue 787 794	monitor
